x

RSS Newsfeeds

See all RSS Newsfeeds

Apr 28, 2017 9:55 AM ET

-Transcatheter Pulmonary Valve Market to Reach $54 Million by 2025 – Increasing Number of Clinical Trials Pipeline by Various Public & Private Players

iCrowdNewswire - Apr 28, 2017

M2 PRESSWIRE-April 28, 2017-Transcatheter Pulmonary Valve Market to Reach $54 Million by 2025 – Increasing Number of Clinical Trials Pipeline by Various Public & Private Players
(C)1994-2017 M2 COMMUNICATIONS

RDATE:28042017

Dublin – Research and Markets has announced the addition of the “Transcatheter Pulmonary Valve Market, 2014-2025” report to their offering.

The global transcatheter pulmonary valve market is expected to reach a value of USD 54.1 million by 2025. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2015, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Companies Mentioned

– Boston Scientific Corporation
– Braile Biomedica
– Direct Flow Medical, Inc.
– Edward Lifesciences Corporation
– JenaValve Technology, Inc.
– Medtronic
– St. Jude Medical
– SYMETIS SA
– Xeltis
– Venus Medtech
– LivaNova PLC.(Sorin Group)
– Cryolife, Inc.
– Colibri Heart Valve, LLC

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Transcatheter Pulmonary Valve Market Variables, Trends & Scope

4 Transcatheter Pulmonary Valve: Technology Estimates & Trend Analysis

5 Transcatheter Pulmonary Valve: End-Use Estimates & Trend Analysis

6 Transcatheter Pulmonary Valve: Application Estimates & Trend Analysis

7 Transcatheter Pulmonary Valve: Raw Material Estimates & Trend Analysis

8 Transcatheter Pulmonary Valve: Regional Estimates & Trend Analysis, by Technology, End-Use, Application, and Raw Material

9 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/m8klx3/transcatheter

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
[email protected]
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Cardiovascular Devices (http://www.researchandmarkets.com/categories.asp?cat_id=233&campaign_id=m8klx3)


((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to [email protected])).

Via iCrowdNewswire
Tags: , Wire, M2 Presswire
View Related News >